Skip to content

Improving Human sperm motility using phosphodiesterase inhibitors

Screening of sperm specific phosphodiesterase inhibitors for their effect on human ejaculated and testicular sperm motility enhancement in vitro

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033477
Enrollment
50
Registered
2021-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: R99- Ill-defined and unknown cause of mortality

Interventions

Intervention1: experimental study: no intervention to the patient. The left over semen sample after routine semen analysis is used for experimental study Control Intervention1: sperm specific Phosphod

Sponsors

Kasturba Medical College Manipal
Lead Sponsor
Manipal Academy Of Higher Education Manipal
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: all semen samples having sperm from adult men

Exclusion criteria

Exclusion criteria: azoospermia

Design outcomes

Primary

MeasureTime frame
male infertility treatment in vitro enhancing sperm motilityTimepoint: 1 year

Secondary

MeasureTime frame
experimental study to improve sperm motility in vitroTimepoint: 1 year

Countries

India

Contacts

Public ContactSandhya Kumari M V

Kasturba Medical College, Manipal, Manipal Academy Of Higher Education, Manipal

sandhya.patil@manipal.edu8660835019

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026